Free Trial
→ The end may be near for these iconic stocks (From Chaikin Analytics) (Ad)tc pixel
NASDAQ:ACON

Aclarion Q3 2026 Earnings Date & Estimates

Aclarion logo
$1.85 -0.10 (-5.28%)
Closing price 10/16/2026 04:00 PM Eastern
Extended Trading
$1.84 -0.01 (-0.27%)
As of 10/16/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Aclarion is estimated to report Q3 2026 earnings on Wednesday, November 11, 2026, before market opens. The conference call is scheduled for November 12, 2026 at 12:30 PM ET.

Research:ProfileEarnings HistoryForecast

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
Before Market Opens
Conference Call Date
Conference Call
12:30 PM ET
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from Aclarion in Q3 2026

Aclarion is expected to post earnings of -$1.15 per share on revenue of $0.03 million. In the same quarter a year earlier Aclarion reported -$2.93 per share on revenue of $0.02 million. Aclarion last reported on August 6, 2026, posting -$1.12 per share and missing the -$1.05 consensus estimate. Aclarion has beaten the consensus EPS estimate in 2 of its last 5 quarters.

Consensus Estimates

Consensus EPS
-$1.15
Expected Revenue
$0.03 million
Prior-Year EPS
-$2.93
Prior-Year Revenue
$0.02 million
Expected Revenue Growth
+68.9%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
-$1.12 (Missed by -$0.07)
Last Quarter Revenue
$0.03 million
EPS Beat Rate
2 of last 5 quarters

Prepare for the Q3 2026 Call

Aclarion Q3 2026 Earnings FAQ

Aclarion (NASDAQ:ACON) is estimated to report Q3 2026 earnings on Wednesday, November 11, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it.

Aclarion's Q3 2026 earnings conference call is scheduled for Thursday, November 12, 2026 at 12:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Aclarion to post earnings of -$1.15 per share for Q3 2026.

The consensus revenue estimate for Aclarion is $0.03 million for Q3 2026.

Aclarion Earnings Headlines

Aclarion to Present at the 20th Annual LD Micro Main Event
October 13, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/10/13/3379508/0/en/aclarion-to-present-at-the-20th-annual-ld-micro-main-event.html
Aclarion Updates CLARITY Enrollment Criteria, Keeps Trial Timeline On Track
October 8, 2026  |  rttnews.comhttps://www.rttnews.com/3697564/aclarion-updates-clarity-enrollment-criteria-keeps-trial-timeline-on-track.aspx
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel
 |  Profits Run (Ad)
Aclarion Broadens CLARITY Trial Enrollment Criteria to Accelerate Enrollment
October 8, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/10/08/3377107/0/en/aclarion-broadens-clarity-trial-enrollment-criteria-to-accelerate-enrollment.html
Aclarion Welcomes NYU Langone Health to CLARITY Trial Network, Now Enrolling at Eleven Sites
September 29, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/29/3370652/0/en/aclarion-welcomes-nyu-langone-health-to-clarity-trial-network-now-enrolling-at-eleven-sites.html
Aclarion Announces Addition of University of Arizona College of Medicine – Phoenix as CLARITY Trial Site
August 20, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/20/3348232/0/en/aclarion-announces-addition-of-university-of-arizona-college-of-medicine-phoenix-as-clarity-trial-site.html
See More Aclarion Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Aclarion? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aclarion and other key companies, straight to your email.

About Aclarion

Aclarion (NASDAQ:ACON) (NASDAQ: ACON) is a healthcare technology company focused on improving the diagnosis and treatment planning of chronic low back pain. The company develops software designed to help physicians identify the spinal discs that may be contributing to a patient’s pain.

Its primary product, Nociscan, is a cloud-based platform that analyzes magnetic resonance spectroscopy data along with other imaging information. The system generates quantitative assessments, including Nociscores, intended to provide additional insight into disc health and support physicians in evaluating potential treatment options.

Aclarion’s technology is designed for use by spine specialists, radiologists, imaging centers and other healthcare providers. The company has focused on commercializing its platform in the United States and expanding access through clinical and healthcare-provider relationships. Its software-based approach is intended to complement existing imaging and clinical evaluation methods rather than replace physician judgment.

View Aclarion Profile
Earnings Tools